Display options
Cite
Sallem F, Haji R, Vervandier-Fasseur D, et al. Elaboration of Trans-Resveratrol Derivative-Loaded Superparamagnetic Iron Oxide Nanoparticles for Glioma Treatment. Nanomaterials (Basel). 2019;9(2)doi: 10.3390/nano9020287.
Sallem, F., Haji, R., Vervandier-Fasseur, D., Nury, T., Maurizi, L., Boudon, J., Lizard, G., & Millot, N. (2019). Elaboration of Trans-Resveratrol Derivative-Loaded Superparamagnetic Iron Oxide Nanoparticles for Glioma Treatment. Nanomaterials (Basel, Switzerland), 9(2), . https://doi.org/10.3390/nano9020287
Sallem, Fadoua, et al. "Elaboration of Trans-Resveratrol Derivative-Loaded Superparamagnetic Iron Oxide Nanoparticles for Glioma Treatment." Nanomaterials (Basel, Switzerland) vol. 9,2 (2019). doi: https://doi.org/10.3390/nano9020287
Sallem F, Haji R, Vervandier-Fasseur D, Nury T, Maurizi L, Boudon J, Lizard G, Millot N. Elaboration of Trans-Resveratrol Derivative-Loaded Superparamagnetic Iron Oxide Nanoparticles for Glioma Treatment. Nanomaterials (Basel). 2019 Feb 18;9(2). doi: 10.3390/nano9020287. PMID: 30781702; PMCID: PMC6409721.
Copy Download .nbib Format: NLM
Share it on

Nanomaterials (Basel). 2019 Feb 18;9(2). doi: 10.3390/nano9020287.

Elaboration of Trans-Resveratrol Derivative-Loaded Superparamagnetic Iron Oxide Nanoparticles for Glioma Treatment.

Nanomaterials (Basel, Switzerland)

Fadoua Sallem, Rihab Haji, Dominique Vervandier-Fasseur, Thomas Nury, Lionel Maurizi, Julien Boudon, Gérard Lizard, Nadine Millot

Affiliations

  1. Laboratoire Interdisciplinaire Carnot de Bourgogne (ICB), UMR 6303 CNRS/Université Bourgogne Franche-Comté, 21000 Dijon, France. [email protected].
  2. Institut de Chimie Moléculaire de l'Université de Bourgogne (ICMUB), UMR 6302 CNRS/Université Bourgogne Franche-Comté, 21000 Dijon, France. [email protected].
  3. Institut de Chimie Moléculaire de l'Université de Bourgogne (ICMUB), UMR 6302 CNRS/Université Bourgogne Franche-Comté, 21000 Dijon, France. [email protected].
  4. Laboratoire Bio-PeroxIL, EA7270, Université de Bourgogne Franche-Comté/Inserm, 21000 Dijon, France. [email protected].
  5. Laboratoire Interdisciplinaire Carnot de Bourgogne (ICB), UMR 6303 CNRS/Université Bourgogne Franche-Comté, 21000 Dijon, France. [email protected].
  6. Laboratoire Interdisciplinaire Carnot de Bourgogne (ICB), UMR 6303 CNRS/Université Bourgogne Franche-Comté, 21000 Dijon, France. [email protected].
  7. Laboratoire Bio-PeroxIL, EA7270, Université de Bourgogne Franche-Comté/Inserm, 21000 Dijon, France. [email protected].
  8. Laboratoire Interdisciplinaire Carnot de Bourgogne (ICB), UMR 6303 CNRS/Université Bourgogne Franche-Comté, 21000 Dijon, France. [email protected].

PMID: 30781702 PMCID: PMC6409721 DOI: 10.3390/nano9020287

Abstract

In this work, new nanohybrids based on superparamagnetic iron oxide nanoparticles (SPIONs) were elaborated and discussed for the first time as nanovectors of a derivative molecule of trans-resveratrol (RSV), a natural antioxidant molecule, which can be useful for brain disease treatment. The derivative molecule was chemically synthesized (4'-hydroxy-4-(3-aminopropoxy) trans-stilbene: HAPtS) and then grafted onto SPIONs surface using an organosilane coupling agent, which is 3-chloropropyltriethoxysilane (CPTES) and based on nucleophilic substitution reactions. The amount of HAPtS loaded onto SPIONs surface was estimated by thermogravimetric analysis (TGA) and X-ray photoelectron spectroscopy (XPS) analyses at 116 µmol·g

Keywords: drug delivery; glioma; iron oxide superparamagnetic nanoparticles; trans-resveratrol derivative

Conflict of interest statement

The authors declare no conflict of interest.

References

  1. Biochem Biophys Res Commun. 2000 May 27;272(1):212-7 - PubMed
  2. Cancer Res. 2000 Jul 1;60(13):3477-83 - PubMed
  3. J Biol Chem. 2001 Jun 22;276(25):22586-94 - PubMed
  4. Brain Res. 2002 Dec 27;958(2):439-47 - PubMed
  5. Chembiochem. 2004 Mar 5;5(3):261-4 - PubMed
  6. Anticancer Res. 2004 Sep-Oct;24(5A):2783-840 - PubMed
  7. Biomaterials. 2005 Jun;26(18):3995-4021 - PubMed
  8. Mol Nutr Food Res. 2005 May;49(5):472-81 - PubMed
  9. Toxicol Appl Pharmacol. 2007 Nov 1;224(3):274-83 - PubMed
  10. Nat Protoc. 2006;1(5):2315-9 - PubMed
  11. EMBO J. 2007 Jul 11;26(13):3169-79 - PubMed
  12. Biomaterials. 2008 Feb;29(4):487-96 - PubMed
  13. Chem Rev. 2008 Jun;108(6):2064-110 - PubMed
  14. J Agric Food Chem. 2008 Sep 10;56(17):7600-5 - PubMed
  15. Behav Pharmacol. 2009 Jul;20(4):330-6 - PubMed
  16. Mol Neurobiol. 2010 Jun;41(2-3):375-83 - PubMed
  17. Biomaterials. 2010 Aug;31(24):6317-24 - PubMed
  18. Carcinogenesis. 2010 Sep;31(9):1561-6 - PubMed
  19. J Agric Food Chem. 2012 May 9;60(18):4662-71 - PubMed
  20. Toxicol In Vitro. 2013 Mar;27(2):954-63 - PubMed
  21. J Pharm Pharmacol. 2013 Aug;65(8):1158-67 - PubMed
  22. PLoS One. 2013 Nov 20;8(11):e81051 - PubMed
  23. Molecules. 2014 Jun 10;19(6):7679-88 - PubMed
  24. Molecules. 2014 Jun 11;19(6):7850-68 - PubMed
  25. Colloids Surf B Biointerfaces. 2014 Nov 1;123:311-7 - PubMed
  26. Int J Pharm. 2015 Feb 20;479(2):282-90 - PubMed
  27. J Control Release. 2015 May 28;206:49-57 - PubMed
  28. J Biomed Nanotechnol. 2015 Jan;11(1):126-36 - PubMed
  29. Mater Sci Eng C Mater Biol Appl. 2016 Jan 1;58:1160-9 - PubMed
  30. Nanotechnology. 2016 Apr 1;27(13):135604 - PubMed
  31. Mater Sci Eng C Mater Biol Appl. 2016 Jun;63:393-410 - PubMed
  32. J Steroid Biochem Mol Biol. 2017 May;169:123-136 - PubMed
  33. J Control Release. 2016 Aug 10;235:34-47 - PubMed
  34. Int J Pharm. 2016 Jul 25;509(1-2):391-399 - PubMed
  35. Dalton Trans. 2016 Jun 28;45(26):10821-9 - PubMed
  36. J Nanosci Nanotechnol. 2016 Mar;16(3):2453-63 - PubMed
  37. Biomater Sci. 2017 Oct 24;5(11):2212-2225 - PubMed
  38. Dalton Trans. 2017 Nov 14;46(44):15386-15398 - PubMed
  39. Nanomedicine (Lond). 2018 Jun;13(11):1385-1400 - PubMed
  40. Colloids Surf B Biointerfaces. 2018 Oct 1;170:454-462 - PubMed
  41. Lancet. 1993 Feb 20;341(8843):454-7 - PubMed
  42. Magn Reson Imaging. 1993;11(8):1139-45 - PubMed
  43. Int J Clin Pharmacol Res. 1996;16(4-5):77-81 - PubMed
  44. Pathol Biol (Paris). 1997 Apr;45(4):281-90 - PubMed
  45. Physiol Rev. 1998 Apr;78(2):547-81 - PubMed
  46. Mutagenesis. 1998 Mar;13(2):115-26 - PubMed
  47. J Comp Physiol B. 1998 Apr;168(3):149-58 - PubMed

Publication Types